MCL Treatment Revolution: Calquence Powers Progression-Free Life
A promising new treatment option has emerged for patients with mantle cell lymphoma (MCL), a rare and aggressive type...
A promising new treatment option has emerged for patients with mantle cell lymphoma (MCL), a rare and aggressive type...
The National Institutes of Health (NIH) has chosen Advarra as its exclusive single institutional review board (sIRB) for clinical...
Cambridge Cognition, a leader in digital brain health assessment solutions, and The Michael J. Fox Foundation for Parkinson’s Disease...
Remepy, a pioneer in “hybrid drugs,” has secured $15 million in funding, led by NFX and supported by several...
SecondWave Systems has made a breakthrough in the treatment of rheumatoid arthritisarthritis (RA) with their novel ultrasonic stimulation technology....
The PREVENT trial is a groundbreaking clinical study investigating the VentFree Respiratory Muscle Stimulator’s efficacy in reducing the duration...
The global molecular farming market is poised to witness significant growth, expanding from $454.1 million in 2023 to a...
Akili, Inc. announced several corporate developments, including an amendment to its partnership with Shionogi & Co. The amended agreement...
Qlaris Bio, a biotechnology company specializing in ophthalmic diseases, secured $24 million in Series B financing. The round was...
TriSalus Life Sciences recently secured a $50 million debt facility from OrbiMed. This financing aims to support TriSalus’ expansion...